FDA Import Refusal 799-4926180-1/21/2 — Glaxo Wellcome S.A.

Glaxo Wellcome S.A. — FEI 3004195227

The FDA refused shipment 799-4926180-1/21/2 from Glaxo Wellcome S.A. (Spain) on Mar 9, 2018. The refused product falls under Drugs and Biologics — FLUTICASONE PROPIONATE (BRONCHODILATOR). Cited charge: 75 This firm has 5 or more other import refusals on record.